×
About 8,983 results

ALLMedicine™ Hepatitis B Virus Center

Research & Reviews  3,415 results

Systematic review with meta-analysis: the impact of functional cure on clinical outcome...
https://doi.org/10.1111/apt.16659
Alimentary Pharmacology & Therapeutics; Vittal A, Sharma D et. al.

Dec 2nd, 2021 - Although hepatitis B surface antigen (HBsAg) loss is considered the ideal therapeutic endpoint for the treatment of chronic hepatitis B virus (HBV) infection, its impact on clinical outcomes remains uncertain. To assess the impact of HBsAg loss on...

Significant metabolic alterations in patients with hepatitis B virus replication observ...
https://doi.org/10.1080/1061186X.2021.2009841
Journal of Drug Targeting; Yu L, Zeng Z et. al.

Dec 1st, 2021 - Until now, the metabolic effects of hepatitis B virus (HBV) replication on the progression of hepatic diseases (hepatitis, cirrhosis, and liver cancer) and liver functions have remained unexplored. Thus, a total of 199 hepatic disease patients wit...

State of the art treatment of HBV hepatocellular carcinoma and the role of HBsAg post l...
https://doi.org/10.1111/liv.15124
Liver International : Official Journal of the Internation... Schemmer P, Burra P et. al.

Dec 1st, 2021 - Chronic hepatitis B virus (HBV) infection is the major aetiology of hepatocellular carcinoma (HCC). The optimal goal of therapy, hepatitis B surface antigen (HBsAg) loss and anti-HBs production, is achieved rarely and HBsAg-associated HCC risk is ...

see more →

Guidelines  4 results

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS B VIRUS.
https://doi.org/10.1016/j.clinre.2021.101773
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.

Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: A...
https://doi.org/10.1200/JCO.20.01757
Journal of Clinical Oncology : Official Journal of the Am... Hwang JP, Feld JJ et. al.

Jul 28th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management. All patients anticipating systemic anticancer therapy should be tested for HBV by 3 tests-hepatitis B surface an...

Management of hepatitis B virus infection, updated Swedish guidelines.
https://doi.org/10.1080/23744235.2019.1675903
Infectious Diseases (London, England); Westin J, Aleman S et. al.

Oct 16th, 2019 - Despite access to effective antiviral drugs and vaccines, hepatitis B virus (HBV) infection remains a major health issue worldwide. HBV is highly infectious and may cause chronic infection, progressive liver damage, hepatocellular cancer (HCC) and...

Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837403
MMWR. Recommendations and Reports : Morbidity and Mortali... Schillie S, Vellozzi C et. al.

Jun 26th, 2018 - HEPATITIS B VIRUS (HBV) IS TRANSMITTED VIA BLOOD OR SEXUAL CONTACT. PERSONS WITH CHRONIC HBV INFECTION ARE AT INCREASED RISK FOR CIRRHOSIS AND LIVER CANCER AND REQUIRE MEDICAL CARE. THIS REPORT UPDATES AND SUMMARIZES PREVIOUSLY PUBLISHED RECOMMEND...

see more →

Drugs  13 results see all →

News  161 results

The Evolution of HBV, From Hunter-Gatherers to Today
https://www.medscape.com/viewarticle/960518

Oct 8th, 2021 - The prehistoric origins of the hepatitis B virus are painted in new color by a new study analyzing the largest ever dataset of ancient viral genomes. What to know: The hepatitis B virus (HBV) has been infecting humans for millennia, according to D...

Low RA Flare Rate Reported After Pfizer COVID Vaccination
https://www.medscape.com/viewarticle/958869

Sep 16th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Patients with rheumatoid arthritis in remission had a rate of flare following vaccination with the Pfizer/BioNtech COVID-19 vaccine that appears t...

HBV Screening Often Incomplete or Forgone When Starting Tocilizumab, Tofacitinib
https://www.medscape.com/viewarticle/956348

Aug 10th, 2021 - People beginning treatment with the immunosuppressive drugs tocilizumab (Actemra, Genentech USA Inc) or tofacitinib (Xeljanz, Pfizer Inc) are infrequently screened for hepatitis B virus (HBV) infection, according to a new study of patients with rh...

New Antiviral Drug Promising Against HBV
https://www.medscape.com/viewarticle/955063

Jul 21st, 2021 - NEW YORK (Reuters Health) - RO7049389, a hepatitis B virus (HBV) core protein allosteric modulator, appears safe and shows antiviral action in patients with chronic HBV infection, according to a small company-funded study. "These results provide p...

Tri-antigenic Vaccine Prevents HBV Infection in Adults
https://www.medscape.com/viewarticle/952116

Jun 1st, 2021 - NEW YORK (Reuters Health) - A tri-antigenic hepatitis B vaccine (TAV) effectively prevented hepatitis B virus (HBV) infection in adults, was somewhat more effective than a mono-antigenic vaccine (MAV) comparator, but had higher side effect rates i...

see more →